Prof. Dr. Lars Nitschke

Professur für Genetik

BAFF, IL-4 and IL-21 separably program germinal center-like phenotype acquisition, BCL6 expression, proliferation and survival of CD40L-activated B cells in vitro (2019) Robinson MJ, Pitt C, Brodie EJ, Valk AM, O'Donnell K, Nitschke L, Jones S, Tarlinton DM Journal article A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice (2019) Wagner F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution Pten controls B-cell responsiveness and germinal center reaction by regulating the expression of IgD BCR (2019) Setz CS, Khadour A, Renna V, Iype J, Gentner E, He X, Datta M, et al. Journal article Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies (2018) Wagner F, Brandl C, Emmerich C, Mackensen A, Nitschke L, Müller F Conference contribution CD83 expression is essential for Treg cell differentiation and stability (2018) Döbbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, Bassler K, et al. Journal article Murine eosinophil development and allergic lung eosinophilia are largely dependent on the signaling adaptor GRB2 (2018) Willebrand R, Dietschmann A, Nitschke L, Krappmann S, Vöhringer D Journal article The CD83 molecule expressed by dendritic cells is a checkpoint to regulate resolution of inflammation as well as homeostasis within periphery and CNS (2018) Wild A, Krzyzak L, Mattner J, Winkler T, Nitschke L, Steinkasserer A Conference contribution New Human CD22/Siglec-2 Ligands with a Triazole Glycoside. (2017) Prescher H, Schweizer A, Kuhfeldt E, Nitschke L, Brossmer R Journal article Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion (2017) Prescher H, Frank M, Guetgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R Journal article Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22 (2016) Özgör L, Brandl C, Shock A, Nitschke L Journal article